Bank of New York Mellon’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bank of New York Mellon’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-493,447	Closed	-$9.21M	–	4766
2022 Q1	$9.21M	Buy	493,447 +8,634	+2%	+$155K	﹤0.01%	2108
2021 Q4	$10.4M	Buy	484,813 +66,835	+16%	+$1.32M	﹤0.01%	2081
2021 Q3	$7.72M	Buy	417,978 +90,921	+28%	+$1.83M	﹤0.01%	2260
2021 Q2	$7M	Buy	327,057 +57,249	+21%	+$1.16M	﹤0.01%	2323
2021 Q1	$5.21M	Buy	+269,808	New	+$4.75M	﹤0.01%	2435

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of New York Mellon's OCDX Position: Q2 2022 in Review

Bank of New York Mellon sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 493,447 shares — an estimated $9.21M sold.

Bank of New York Mellon first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $10.4M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Bank of New York Mellon reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 493,447 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $9.21M.
Bank of New York Mellon first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Bank of New York Mellon's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $10.4M in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.